United States - English - NLM (National Library of Medicine)

actavis pharma, inc. - levetiracetam (unii: 44yrr34555) (levetiracetam - unii:44yrr34555) - levetiracetam 500 mg - levetiracetam extended-release tablets are indicated as adjunctive therapy in the treatment of partial onset seizures in patients 12 years of age and older with epilepsy. levetiracetam extended-release tablets are contraindicated in patients with a hypersensitivity to levetiracetam. reactions have included anaphylaxis and angioedema [see warnings and precautions (5.4) ]. levetiracetam extended-release tablets levels may decrease during pregnancy [see  warnings and precautions (5.9) ]. pregnancy category c there are no adequate and well-controlled studies in pregnant women. in animal studies, levetiracetam produced evidence of developmental toxicity, including teratogenic effects, at doses similar to or greater than human therapeutic doses. levetiracetam extended-release tablets should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. oral administration of levetiracetam to female rats throughout pregnancy and lactation led to increased incidences of minor fetal

United States - English - NLM (National Library of Medicine)

denton pharma, inc. dba northwind pharmaceuticals - diltiazem hydrochloride (unii: olh94387te) (diltiazem - unii:ee92bbp03h) - dilt-xr [diltiazem hydrochloride extended-release capsules, usp (once-a-day dosage)] are indicated for the treatment of hypertension. diltiazem hydrochloride may be used alone or in combination with other antihypertensive medications, such as diuretics. dilt-xr [diltiazem hydrochloride extended-release capsules, usp (once-a-day dosage)] are indicated for the management of chronic stable angina. diltiazem hydrochloride is contraindicated in: (1) patients with sick sinus syndrome except in the presence of a functioning ventricular pacemaker; (2) patients with second or third degree av block except in the presence of a functioning ventricular pacemaker; (3) patients with hypotension (less than 90 mmhg systolic); (4) patients who have demonstrated hypersensitivity to the drug; and (5) patients with acute myocardial infarction and pulmonary congestion as documented by x-ray on admission.

European Union - English - EMA (European Medicines Agency)

plusultra pharma gmbh - sirolimus - angiofibroma; tuberous sclerosis - hyftor is indicated for the treatment of facial angiofibroma associated with tuberous sclerosis complex in adults and paediatric patients aged 6 years and older.

Panama - English - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

bma pharma, s.a. - triclosÁn - triclosÁn....0.1 g / azufre sublimado....3 g / resorcinol....2 g

Panama - English - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

bma pharma, s.a. - triclosÁn - triclosÁn....0.1 g / azufre sublimado....3 g / resorcinol....2 g

New Zealand - English - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - diltiazem hydrochloride 30mg;  ;  ;  ;   - film coated tablet - 30 mg - active: diltiazem hydrochloride 30mg         excipient: aluminium hydroxide gel hydrogenated castor oil lactose monohydrate magnesium stearate methacrylic acid copolymer opadry white y-1r-7000b purified talc

New Zealand - English - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - diltiazem hydrochloride 60mg;  ;  ;  ;   - film coated tablet - 60 mg - active: diltiazem hydrochloride 60mg         excipient: aluminium hydroxide gel hydrogenated castor oil lactose monohydrate magnesium stearate methacrylic acid copolymer opadry white y-1r-7000b purified talc

Singapore - English - HSA (Health Sciences Authority)

msd pharma (singapore) pte. ltd. - raltegravir potassium 108.6 mg eqv raltegravir - tablet, chewable - 100 mg - raltegravir potassium 108.6 mg eqv raltegravir 100 mg

Singapore - English - HSA (Health Sciences Authority)

msd pharma (singapore) pte. ltd. - raltegravir potassium 27.16 mg eqv raltegravir - tablet, chewable - 25 mg - raltegravir potassium 27.16 mg eqv raltegravir 25 mg

Singapore - English - HSA (Health Sciences Authority)

astrazeneca singapore pte ltd - saxagliptin hydrochloride (anhydrous) 2.79 mg eqv saxagliptin - tablet, film coated - 2.5 mg - saxagliptin hydrochloride (anhydrous) 2.79 mg eqv saxagliptin 2.5 mg